AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

The pharmaceutical industry is on the verge of a significant transformation due to the emergence of artificial intelligence ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

Acellera Therapeutics focuses on drug discovery by merging AI-driven innovation with computational scaleability, aiming to ...

Siddhartha Mukherjee and Reid Hoffman’s Manas AI aims to help design and screen molecules that ... we can now help the world's best drug development scientists to augment and amplify their ...

From accelerating drug development and clinical trials to supercharging collaboration, machine learning-enhanced healthcare ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

GenAI is transforming how those in drug discovery and development approach decision ... Sponsors can inform better trial design at an individual study level by using AI to understand current standard ...